Liabilities / Assets
93rd percentile
Higher debt load relative to assets than 93% of similar nonprofits.
990EZ • Fiscal year 2020 • EIN 10-0003432
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
93rd percentile
Higher debt load relative to assets than 93% of similar nonprofits.
Liabilities / Revenue
96th percentile
Higher debt load relative to revenue than 96% of similar nonprofits.
Net Margin
21st percentile
Higher net margin than 21% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
19th percentile
Faster asset growth than 19% of similar nonprofits.
Revenue Growth
9th percentile
Faster revenue growth than 9% of similar nonprofits.
Assets
Down$207,235
Down $55,302 (-21%) from 2019
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Down$199,618
Down $26,195 (-12%) from 2019
Revenue
Down$132,257
Down $478,024 (-78%) from 2019
Expenses
Down$161,248
Down $445,279 (-73%) from 2019
Net Income
Down-$28,991
Down $32,745 (-872%) from 2019
This 2020 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The Institute specializes in research on diseases whose origin and treatment are rooted in cell membrane mechanics. Such diseases include arteriosclerosis, osteoporosis, Alzheimer's and cardiovascular disease. Other biomechanical research includes anti-inflammatory biomaterials development and musculoskeletal properties research. The Institute receives substantially all of its revenue through grants from the National Institutes of Health.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2020 • Form 990EZSummary only. Only limited summary data is available for this year.